MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

Search

Myomo Inc

Închisă

4.33 -7.48

Rezumat

Modificarea prețului

24h

Curent

Minim

4.13

Maxim

4.35

Indicatori cheie

By Trading Economics

Venit

-5.2M

-260K

Vânzări

2.9M

12M

EPS

-0.01

Marjă de profit

-2.155

Angajați

184

EBITDA

712K

-245K

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+112.64% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

12M

167M

Deschiderea anterioară

11.81

Închiderea anterioară

4.33

Myomo Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 apr. 2025, 22:38 UTC

Acțiuni populare

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

7 apr. 2025, 00:00 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Stonepeak's Total Contribution Lower Than Nominal Equity Interest Give Accelerated Spend

6 apr. 2025, 23:58 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Deal 'a Material Step' Toward Readiness for Final Investment Decision

6 apr. 2025, 23:58 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Deal 'Significantly Reduces' Company's Capex Profile

6 apr. 2025, 23:57 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Stonepeak to Contribute 75% of Project Capex in Both 2025, 2026

6 apr. 2025, 23:57 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Stonepeak to Provide $5.7 Billion Towards Expected Project Capex

6 apr. 2025, 23:57 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 apr. 2025, 23:57 UTC

Market Talk

Nervous Start For AUD/USD; Watch on CNY Fix -- Market Talk

6 apr. 2025, 23:56 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Signs Deal With Stonepeak for Sale of 40% Interest in Louisiana LNG Infrastructure

6 apr. 2025, 23:52 UTC

Market Talk

Gold Slips; Likely Unwinding of Long Positions to Raise Cash -- Market Talk

6 apr. 2025, 23:39 UTC

Market Talk

Oil Futures Slide on Fears of Weakening Global Demand -- Market Talk

6 apr. 2025, 23:39 UTC

Market Talk

Nikkei May Fall as U.S. Tariffs Weigh on Global Econ Outlook -- Market Talk

6 apr. 2025, 23:39 UTC

Market Talk

Global Equities Roundup: Market Talk

6 apr. 2025, 23:38 UTC

Achiziții, Fuziuni, Preluări

Challenger: Reinsurance Relationship With MS Primary Will Continue

6 apr. 2025, 23:38 UTC

Achiziții, Fuziuni, Preluări

Challenger: Acquisition at 53% Premium to Most Recent Share Price

6 apr. 2025, 23:37 UTC

Achiziții, Fuziuni, Preluări

Challenger: Acquisition Subject to Regulatory Approvals

6 apr. 2025, 23:36 UTC

Achiziții, Fuziuni, Preluări

Challenger: Dai-ichi Life Acquiring Stake From MS&AD Insurance

6 apr. 2025, 23:36 UTC

Achiziții, Fuziuni, Preluări

Challenger: Dai-ichi Life Paying About A$8.46/Share

6 apr. 2025, 23:35 UTC

Achiziții, Fuziuni, Preluări

Challenger: Dai-ichi Life Agrees to Acquire 15.1% Interest

6 apr. 2025, 21:58 UTC

Top știri

Bitcoin Is Falling Amid Global Market Swoon -- Barrons.com

6 apr. 2025, 13:00 UTC

Top știri

Trump Promised to Lower Energy Prices -- But It Wasn't Supposed to Be Like This -- WSJ

5 apr. 2025, 15:45 UTC

Top știri

Republicans Advance Trump's Tax Cuts After Late-Night Session -- Update

5 apr. 2025, 15:00 UTC

Top știri

U.S.-Stock Funds Have a Quarter to Forget -- Journal Report

5 apr. 2025, 15:00 UTC

Top știri

The Complicated Relationship Between Consumer Sentiment and Stocks -- Journal Report

5 apr. 2025, 14:38 UTC

Top știri

Trump's Trade Broadside Puts Chinese Economy Under Heavy Pressure -- WSJ

5 apr. 2025, 06:44 UTC

Top știri

Republicans Advance Trump's Tax Cuts After Late-Night Session -- WSJ

5 apr. 2025, 01:00 UTC

Achiziții, Fuziuni, Preluări

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ

5 apr. 2025, 01:00 UTC

Achiziții, Fuziuni, Preluări

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ -2-

4 apr. 2025, 21:53 UTC

Market Talk

Maxeon's Supply Chain Move at Critical Time for Solar Panel Cos -- Market Talk

4 apr. 2025, 21:44 UTC

Top știri
Achiziții, Fuziuni, Preluări

Trump Grants 75-Day Extension to Reach TikTok Deal -- 3rd Update

Comparație

Modificare preț

Myomo Inc Așteptări

Obiectiv de preț

By TipRanks

112.64% sus

Prognoză pe 12 luni

Medie 9.25 USD  112.64%

Maxim 11 USD

Minim 6.75 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMyomo Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

5 ratings

5

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Myomo Inc

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.